Ankush D Jamthikar1, Deep Gupta1, Luca Saba2, Narendra N Khanna3, Klaudija Viskovic4, Sophie Mavrogeni5, John R Laird6, Naveed Sattar7, Amer M Johri8, Gyan Pareek9, Martin Miner10, Petros P Sfikakis11, Athanasios Protogerou12, Vijay Viswanathan13, Aditya Sharma14, George D Kitas15, Andrew Nicolaides16, Raghu Kolluri17, Jasjit S Suri18. 1. Department of Electronics and Communication Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra, India. 2. Department of Radiology, University of Cagliari, Italy. 3. Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi, India. 4. Department of Radiology and Ultrasound, University Hospital for Infectious Diseases, Croatia. 5. Cardiology Clinic, Onassis Cardiac Surgery Center, Athens, Greece. 6. Heart and Vascular Institute, Adventist Health St. Helena, St Helena, CA, USA. 7. Institute of Cardiovascular & Medical Sciences, University of Glasgow, Scotland, UK. 8. Department of Medicine, Division of Cardiology, Queen's University, Kingston, Ontario, Canada. 9. Minimally Invasive Urology Institute, Brown University, Providence, RI, USA. 10. Men's Health Center, Miriam Hospital Providence, Rhode Island, USA. 11. Rheumatology Unit, National Kapodistrian University of Athens, Greece. 12. Department of Cardiovascular Prevention & Research Unit Clinic & Laboratory of Pathophysiology, National and Kapodistrian Univ. of Athens, Greece. 13. MV Hospital for Diabetes and Professor M Viswanathan Diabetes Research Centre, Chennai, India. 14. Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA. 15. R & D Academic Affairs, Dudley Group NHS Foundation Trust, Dudley, United Kingdom. 16. Vascular Screening and Diagnostic Centre and University of Nicosia Medical School, Nicosia, Cyprus. 17. OhioHealth Heart and Vascular, Ohio, USA. 18. Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, USA. Electronic address: jasjit.suri@atheropoint.com.
Abstract
RECENT FINDINGS: Cardiovascular disease (CVD) is the leading cause of mortality and poses challenges for healthcare providers globally. Risk-based approaches for the management of CVD are becoming popular for recommending treatment plans for asymptomatic individuals. Several conventional predictive CVD risk models based do not provide an accurate CVD risk assessment for patients with different baseline risk profiles. Artificial intelligence (AI) algorithms have changed the landscape of CVD risk assessment and demonstrated a better performance when compared against conventional models, mainly due to its ability to handle the input nonlinear variations. Further, it has the flexibility to add risk factors derived from medical imaging modalities that image the morphology of the plaque. The integration of noninvasive carotid ultrasound image-based phenotypes with conventional risk factors in the AI framework has further provided stronger power for CVD risk prediction, so-called "integrated predictive CVD risk models." PURPOSE: of the review: The objective of this review is (i) to understand several aspects in the development of predictive CVD risk models, (ii) to explore current conventional predictive risk models and their successes and challenges, and (iii) to refine the search for predictive CVD risk models using noninvasive carotid ultrasound as an exemplar in the artificial intelligence-based framework. CONCLUSION: Conventional predictive CVD risk models are suboptimal and could be improved. This review examines the potential to include more noninvasive image-based phenotypes in the CVD risk assessment using powerful AI-based strategies.
RECENT FINDINGS:Cardiovascular disease (CVD) is the leading cause of mortality and poses challenges for healthcare providers globally. Risk-based approaches for the management of CVD are becoming popular for recommending treatment plans for asymptomatic individuals. Several conventional predictive CVD risk models based do not provide an accurate CVD risk assessment for patients with different baseline risk profiles. Artificial intelligence (AI) algorithms have changed the landscape of CVD risk assessment and demonstrated a better performance when compared against conventional models, mainly due to its ability to handle the input nonlinear variations. Further, it has the flexibility to add risk factors derived from medical imaging modalities that image the morphology of the plaque. The integration of noninvasive carotid ultrasound image-based phenotypes with conventional risk factors in the AI framework has further provided stronger power for CVD risk prediction, so-called "integrated predictive CVD risk models." PURPOSE: of the review: The objective of this review is (i) to understand several aspects in the development of predictive CVD risk models, (ii) to explore current conventional predictive risk models and their successes and challenges, and (iii) to refine the search for predictive CVD risk models using noninvasive carotid ultrasound as an exemplar in the artificial intelligence-based framework. CONCLUSION: Conventional predictive CVD risk models are suboptimal and could be improved. This review examines the potential to include more noninvasive image-based phenotypes in the CVD risk assessment using powerful AI-based strategies.
Authors: Amer M Johri; Laura E Mantella; Ankush D Jamthikar; Luca Saba; John R Laird; Jasjit S Suri Journal: Int J Cardiovasc Imaging Date: 2021-05-29 Impact factor: 2.357
Authors: Luca Saba; Skandha S Sanagala; Suneet K Gupta; Vijaya K Koppula; Amer M Johri; Narendra N Khanna; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; Durga P Misra; Vikas Agarwal; Aditya M Sharma; Vijay Viswanathan; Vijay S Rathore; Monika Turk; Raghu Kolluri; Klaudija Viskovic; Elisa Cuadrado-Godia; George D Kitas; Neeraj Sharma; Andrew Nicolaides; Jasjit S Suri Journal: Ann Transl Med Date: 2021-07
Authors: Mainak Biswas; Luca Saba; Tomaž Omerzu; Amer M Johri; Narendra N Khanna; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; Antonella Balestrieri; Petros P Sfikakis; Athanasios Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Raghu Kolluri; Aditya Sharma; Vijay Viswanathan; Zoltan Ruzsa; Andrew Nicolaides; Jasjit S Suri Journal: J Digit Imaging Date: 2021-06-02 Impact factor: 4.903
Authors: Panagiota Anyfanti; Athanasia Dara; Elena Angeloudi; Eleni Bekiari; Theodoros Dimitroulas; George D Kitas Journal: J Inflamm Res Date: 2021-12-14
Authors: Jasjit S Suri; Mahesh A Maindarkar; Sudip Paul; Puneet Ahluwalia; Mrinalini Bhagawati; Luca Saba; Gavino Faa; Sanjay Saxena; Inder M Singh; Paramjit S Chadha; Monika Turk; Amer Johri; Narendra N Khanna; Klaudija Viskovic; Sofia Mavrogeni; John R Laird; Martin Miner; David W Sobel; Antonella Balestrieri; Petros P Sfikakis; George Tsoulfas; Athanase D Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Raghu Kolluri; Jagjit S Teji; Mustafa Al-Maini; Surinder K Dhanjil; Meyypan Sockalingam; Ajit Saxena; Aditya Sharma; Vijay Rathore; Mostafa Fatemi; Azra Alizad; Padukode R Krishnan; Tomaz Omerzu; Subbaram Naidu; Andrew Nicolaides; Kosmas I Paraskevas; Mannudeep Kalra; Zoltán Ruzsa; Mostafa M Fouda Journal: Diagnostics (Basel) Date: 2022-06-24
Authors: Jasjit S Suri; Mrinalini Bhagawati; Sudip Paul; Athanasios D Protogerou; Petros P Sfikakis; George D Kitas; Narendra N Khanna; Zoltan Ruzsa; Aditya M Sharma; Sanjay Saxena; Gavino Faa; John R Laird; Amer M Johri; Manudeep K Kalra; Kosmas I Paraskevas; Luca Saba Journal: Diagnostics (Basel) Date: 2022-03-16